Nicholas S. Green - Jul 9, 2024 Form 4 Insider Report for Avid Bioservices, Inc. (CDMO)

Signature
/s/ Stephen Hedberg, by Power of Attorney for Nicholas S. Green
Stock symbol
CDMO
Transactions as of
Jul 9, 2024
Transactions value $
-$57,734
Form type
4
Date filed
7/11/2024, 05:00 PM
Previous filing
Jul 2, 2024
Next filing
Oct 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDMO Common Stock, $0.001 par value Options Exercise +14.4K +7% 220K Jul 9, 2024 Direct F1
transaction CDMO Common Stock, $0.001 par value Sale -$57.7K -7.66K -3.48% $7.54 212K Jul 10, 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDMO Performance Stock Units Options Exercise $0 +548K +105.51% $0.00 1.07M Jul 9, 2024 Common Stock 548K Direct F4, F5
transaction CDMO Restricted Stock Unit Options Exercise $0 +274K +107.37% $0.00 529K Jul 9, 2024 Common Stock 274K Direct F1, F6
transaction CDMO Restricted Stock Units Disposed to Issuer $0 -8.83K -1.67% $0.00 520K Jul 9, 2024 Common Stock 8.83K Direct F1, F7
transaction CDMO Restricted Stock Units Disposed to Issuer $0 -5.57K -1.07% $0.00 514K Jul 9, 2024 Common Stock 5.57K Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
F2 Represents the shares sold by the reporting person pursuant to a contractual election to satisfy tax withholding obligations in connection with the vesting and release of the RSUs described in footnotes 7 and 8. This sale does not represent a discretionary trade by the reporting person.
F3 Represents a weighted average sales price per share. These shares were sold at prices ranging from $7.53 to $7.555. The reporting person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 Each performance stock unit ("PSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
F5 The vesting of the PSUs granted to the reporting person on July 9, 2024 is subject to the Issuer achieving certain fiscal year revenue and adjusted pre-tax net income milestones, each weighted 50%, over three (3) fiscal year performance periods beginning with the Issuer's fiscal year ending April 30, 2025 and continuing through the fiscal year ending April 30, 2027 (each a "Performance Period"). Subject to the Issuer attaining the applicable fiscal year milestones, 1/3rd of the PSUs will vest on the last day of each fiscal year during the Performance Period, subject to the reporting person's continuous service to the Issuer on such vesting dates. The number of PSUs listed is based on a maximum 200% achievement of each milestone during each Performance Period (the "Maximum Performance Target"). If a milestone is achieved at a rate below the Maximum Performance Target, or is not achieved, the corresponding portion of the PSUs that do not vest are forfeited.
F6 RSUs granted to the reporting person on July 9, 2024, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2024, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.
F7 RSUs granted to the reporting person on July 9, 2022, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2022, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.
F8 RSUs granted to the reporting person on July 9, 2021, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2021, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.